Proprietary B-vitamin Complex
Studies of specific B vitamins have demonstrated...
41%
reduced risk of “visually significant Age-related Macular Degeneration (AMD)”1
42%
reduced risk of early AMD with B-vitamin intake2
Coming Soon
PreserVision®
AREDS3
An evolved formula building on PreserVision® AREDS 2. Now with scientifically backed B vitamins designed to help support a wider range of patients.
Includes nutrients that support the body’s natural response to oxidative stress*
Contains NEI-recommended AREDS2 nutrients shown to reduce risk of AMD progression by 25%3,4*†
Adds B vitamins to support cellular metabolism and healthy homocysteine levels5*
*This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
†In moderate-to-advanced AMD patients.
REFERENCES: 1. Christen WG, Glynn RJ, Chew EY, Albert CM, Manson JE. Folic acid, pyridoxine, and cyanocobalamin combination treatment and age-related macular degeneration in women: the Women's Antioxidant and Folic Acid Cardiovascular Study. Arch Intern Med. 2009;169(4):335-41. 2. Merle BMJ, Barthes S, Féart C, Cougnard-Grégoire A, Korobelnik JF, Rougier MB, Delyfer MN, Delcourt C. B Vitamins and Incidence of Advanced Age-Related Macular Degeneration: The Alienor Study. Nutrients. 2022;14(14):2821. 3. Age-Related Eye Disease Study Research Group. AREDS report no. 8. Arch Ophthalmol. 2001;119(10):1417-1436. 4. AREDS2 Research Group, Chew EY, Clemons T, et al. The Age-Related Eye Disease Study 2 (AREDS2). Ophthalmology. 2012;119(11):2282-2289. 5. Poteet J, Koetting C, Vakharia P. Role of B vitamins in preventing the development and progression of age-related macular degeneration. Ophthalmol Ther. 2025. doi:10.1007/ s40123-025-01281-1.
The PreserVision® AREDS3 formula will be studied in a long-term trial, including patients with all stages of AMD, from early to geographic atrophy.
AREDS = age-related eye disease study
Text Size: